{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,2,10]],"date-time":"2024-02-10T00:36:11Z","timestamp":1707525371208},"reference-count":14,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2023,10,7]]},"DOI":"10.7759\/cureus.46612","type":"journal-article","created":{"date-parts":[[2023,10,7]],"date-time":"2023-10-07T07:19:45Z","timestamp":1696663185000},"source":"Crossref","is-referenced-by-count":0,"title":["Managing Stroke Prevention in Hypertrophic Obstructive Cardiomyopathy (HOCM) Patients Without Confirmed Persistent Atrial Fibrillation: A Dilemma of Anticoagulation"],"prefix":"10.7759","author":[{"given":"Christine","family":"Henen","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elise A","family":"Johnson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sergio","family":"Sokol","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.117.029267","article-title":"Clinical profile and consequences of atrial fibrillation in hypertrophic cardiomyopathy","volume":"136","author":"Rowin EJ","year":"2017","unstructured":"Rowin EJ, Hausvater A, Link MS, et al.. Clinical profile and consequences of atrial fibrillation in hypertrophic cardiomyopathy. Circulation. 2017, 136:2420-2436. 10.1161\/CIRCULATIONAHA.117.029267","journal-title":"Circulation"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.3389\/fcvm.2023.1023394","article-title":"Genetic variants, pathophysiological pathways, and oral anticoagulation in patients with hypertrophic cardiomyopathy and atrial fibrillation","volume":"10","author":"Wang S","year":"2023","unstructured":"Wang S, Chen H, Liu C, et al.. Genetic variants, pathophysiological pathways, and oral anticoagulation in patients with hypertrophic cardiomyopathy and atrial fibrillation. Front Cardiovasc Med. 2023, 10:1023394. 10.3389\/fcvm.2023.1023394","journal-title":"Front Cardiovasc Med"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.14740\/cr1437","article-title":"Rare occurrence of apical hypertrophic cardiomyopathy among hispanics","volume":"13","author":"Abdalla MS","year":"2022","unstructured":"Abdalla MS, Pudasainee P, Ramachandran A, Akbar MS. Rare occurrence of apical hypertrophic cardiomyopathy among hispanics. Cardiol Res. 2022, 13:393-397. 10.14740\/cr1437","journal-title":"Cardiol Res"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.7150\/ijms.50167","article-title":"Thromboembolism in patients with hypertrophic cardiomyopathy","volume":"18","author":"Liu L","year":"2021","unstructured":"Liu L, Liu Z, Chen X, He S. Thromboembolism in patients with hypertrophic cardiomyopathy. Int J Med Sci. 2021, 18:727-735. 10.7150\/ijms.50167","journal-title":"Int J Med Sci"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1161\/STROKEAHA.115.012130","article-title":"Stroke and embolic events in hypertrophic cardiomyopathy: risk stratification in patients without atrial fibrillation","volume":"47","author":"Haruki S","year":"2016","unstructured":"Haruki S, Minami Y, Hagiwara N. Stroke and embolic events in hypertrophic cardiomyopathy: risk stratification in patients without atrial fibrillation. Stroke. 2016, 47:936-942. 10.1161\/STROKEAHA.115.012130","journal-title":"Stroke"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijcard.2023.04.008","article-title":"Incidence of stroke in patients with hypertrophic cardiomyopathy in stable sinus rhythm during long-term monitoring","volume":"381","author":"Fumagalli C","year":"2023","unstructured":"Fumagalli C, Bonanni F, Beltrami M, et al.. Incidence of stroke in patients with hypertrophic cardiomyopathy in stable sinus rhythm during long-term monitoring. Int J Cardiol. 2023, 381:70-75. 10.1016\/j.ijcard.2023.04.008","journal-title":"Int J Cardiol"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.18632\/aging.102532","article-title":"Risk of ischemic stroke in patients with hypertrophic cardiomyopathy in the absence of atrial fibrillation - a nationwide cohort study","volume":"11","author":"Lin TT","year":"2019","unstructured":"Lin TT, Sung YL, Ko TY, Lee CK, Lin LY, Juang JJ, Wu CK. Risk of ischemic stroke in patients with hypertrophic cardiomyopathy in the absence of atrial fibrillation - a nationwide cohort study. Aging (Albany NY). 2019, 11:11347-11357. 10.18632\/aging.102532","journal-title":"Aging (Albany NY)"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacl.2017.08.018","article-title":"Evolutional change in epicardial fat and its correlation with myocardial diffuse fibrosis in heart failure patients","volume":"11","author":"Wu CK","year":"2017","unstructured":"Wu CK, Tsai HY, Su MM, et al.. Evolutional change in epicardial fat and its correlation with myocardial diffuse fibrosis in heart failure patients. J Clin Lipidol. 2017, 11:1421-1431. 10.1016\/j.jacl.2017.08.018","journal-title":"J Clin Lipidol"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1161\/01.cir.84.2.527","article-title":"Stroke prevention in atrial fibrillation study. Final results","volume":"84","year":"1991","unstructured":"Stroke prevention in atrial fibrillation study. Final results. Circulation. 1991, 84.527-539. 10.1161\/01.cir.84.2.527","journal-title":"Circulation"},{"key":"ref10","article-title":"Anticoagulation therapy in paroxysmal atrial fibrillation [Article in Norwegian]","volume":"124","author":"Ris\u00f8e C","year":"2004","unstructured":"Ris\u00f8e C, Gjesdal K. Anticoagulation therapy in paroxysmal atrial fibrillation [Article in Norwegian]. Tidsskr Nor Laegeforen. 2004, 124:950-952.","journal-title":"Tidsskr Nor Laegeforen"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1007\/s00399-005-0475-8","article-title":"Asymptomatic atrial fibrillation with systematic screening using tele-ECG--relevance for anticoagulation in paroxysmal atrial fibrillation [Article in German]","volume":"16","author":"Patten M","year":"2005","unstructured":"Patten M. Asymptomatic atrial fibrillation with systematic screening using tele-ECG--relevance for anticoagulation in paroxysmal atrial fibrillation [Article in German]. Herzschrittmacherther Elektrophysiol. 2005, 16:159-164. 10.1007\/s00399-005-0475-8","journal-title":"Herzschrittmacherther Elektrophysiol"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2007.07.076","article-title":"Incidence of stroke in paroxysmal versus sustained atrial fibrillation in patients taking oral anticoagulation or combined antiplatelet therapy: an ACTIVE W Substudy","volume":"50","author":"Hohnloser SH","year":"2007","unstructured":"Hohnloser SH, Pajitnev D, Pogue J, et al.. Incidence of stroke in paroxysmal versus sustained atrial fibrillation in patients taking oral anticoagulation or combined antiplatelet therapy: an ACTIVE W Substudy. J Am Coll Cardiol. 2007, 50:2156-2161. 10.1016\/j.jacc.2007.07.076","journal-title":"J Am Coll Cardiol"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehu359","article-title":"Higher risk of death and stroke in patients with persistent vs. paroxysmal atrial fibrillation: results from the ROCKET-AF Trial","volume":"36","author":"Steinberg BA","year":"2015","unstructured":"Steinberg BA, Hellkamp AS, Lokhnygina Y, et al.. Higher risk of death and stroke in patients with persistent vs. paroxysmal atrial fibrillation: results from the ROCKET-AF Trial. Eur Heart J. 2015, 36:288-296. 10.1093\/eurheartj\/ehu359","journal-title":"Eur Heart J"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-022-19895-x","article-title":"Augmented risk of ischemic stroke in hypertrophic cardiomyopathy patients without documented atrial fibrillation","volume":"12","author":"Choi YJ","year":"2022","unstructured":"Choi YJ, Kim B, Rhee TM, et al.. Augmented risk of ischemic stroke in hypertrophic cardiomyopathy patients without documented atrial fibrillation. Sci Rep. 2022, 12:15785. 10.1038\/s41598-022-19895-x","journal-title":"Sci Rep"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/174170-managing-stroke-prevention-in-hypertrophic-obstructive-cardiomyopathy-hocm-patients-without-confirmed-persistent-atrial-fibrillation-a-dilemma-of-anticoagulation","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T20:08:57Z","timestamp":1707509337000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/174170-managing-stroke-prevention-in-hypertrophic-obstructive-cardiomyopathy-hocm-patients-without-confirmed-persistent-atrial-fibrillation-a-dilemma-of-anticoagulation"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,10,7]]},"references-count":14,"URL":"https:\/\/doi.org\/10.7759\/cureus.46612","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2023,10,7]]}}}